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Critical Evaluation of 2,4-DÕs Breast Cancer Risk
by Renu Gandhi, Serge-Alain Wandji, and Suzanne Snedeker
AuthorÕs Note: The reader is encouraged to read the attached document, Appendix B, which includes an explanation of the BCERF
Breast Carcinogen Classification System, before reading this Critical Evaluation.
I. Chemical Information
A. Common Name:  2,4-D (Worthing, 1983)
B. Chemical Name:  2,4-dichlorophenoxyacetic acid (IUPAC)
(Worthing, 1983)
C. Chemical Formula:  C8H6Cl2O3  (Montgomery, 1993)
D. Trade Names:  AmoxoneÒ, ChloroxoneÒ Crop RiderÒ,
DinoxolÒ, DormoneÒ, EmulsamineÒ, E-3Ò, FernimineÒ,
FernoxoneÒ (ZENECA Agrochemicals), SavageÒ, SalvoÒ
StatesmanÒ (Platte Chemical Co.), Weed-no-MoreÒ (Ciba-
Giegy Ltd), Aqua-KleenÒ, Lawn-KeepÒ, PlanotoxÒ,
DesormoneÒ, EsteronÒ, WeedarÒ, WeedoneÒ (Rhone-Poulenc
Ag Co.) Riverdale 2,4-D, SolutionÒ, WeedestroyÒ (Riverdale
Chemical Co.), NavigateÒ (Applied Biochemists), Weed ProÒ
2,4-D (Cornbelt Chemical Co.), MiracleÒ, WeedtrolÒ (Agchem
Mfg.), PlantgardÒ (Chevron Chemical Co.) (Meister, 1997).
E. Trade Names of Mixes:  TillerÒ (AgrEvo USA Co.),
DuplosanÒ, U 46Ò (BASF AG), Chimac Cop SpecialÒ, Chimac
MixteÒ, Selectone GÒ, Selectyl MDÒ, TrimonalÒ (Chimac-
Agriphar S.A.), MCPP-2,4-D (W.A.Cleary), Nox-DÒ (Crystal
Chemical Inter-America and Duposca), CurtailÒ, LontrelÒ 205,
GrazonÒ P+D, PathwayÒ, TordonÒ 101, ScorpionÒ III
(DowElanco), HerbanilÒ 368 (Herbitecnica Defensivos Agricolas
Ltda.), DurtokÒ 540 (Invequimica S.A.), 2 plus 2Ò (ISK
Biosciences Corp.), Brush-masterÒ, Super TrimecÒ, TrimecÒ
Bentgrass, TrimecÒ Brush Killer, TrimecÒ Classic,
(PBI/Gordon Corp.), DissolveÒ, TriamineÒ, Tri-EsterÒ,
TripletÒ, VeteranÒ 720 (Riverdale Chemicals Co.), ActrilÒ,
EnvertÒ, WeedoneÒ, TrioÒ (Rhone-Poulenc Ag Co.),
WeedmasterÒ (Sandoz Agro, Inc) (Meister, 1997).
F. CAS Registry Number:  94-75-7 (Meister, 1997)
G. Chemical Structure of 2,4-D: (Meister, 1997)
O-CH2-COOH
           Cl
                             
Cl
H. Related Compound:  2,4,5-trichlorophenoxyacetic acid
(2,4,5-T) (Meister, 1997)
II.  History of Use and Usage:
A. History of Use:
The synthesis of 2,4-D was first reported in 1941 (IARC, 1986).
2,4-D is structurally similar to indoleacetic acid (IAA), a
naturally occurring plant hormone. This similarity allows 2,4-D
to mimic the plant hormone and is the basis for the herbicidal
action. 2,4-D was originally developed as a plant growth
regulator, but its more useful herbicidal properties were
discovered in England in 1942 (Lilienfeld and Gallo, 1989). In
1945, Dow Chemical Co. discovered that a 1:1 mixture of 2,4-
D and 2,4,5-T was a more effective herbicide than either of the
two chemicals alone. The mixture was thereafter referred to as
Agent Orange (Lilienfeld and Gallo, 1989). 2,4-D was first
registered for commercial use in 1948 (Munro et al., 1992).
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), was often found as
a trace contaminant of 2,4-D preparations before 1975 (IARC,
1986; Johnson et al., 1992). Agent Orange was used in the
Vietnam war by the U.S. for defoliation and crop destruction
beginning in 1962 and its use increased until 1969, when
concerns over its health effects arose. Production and use of 2,4-
D decreased markedly in the U.S. after 1969 due to
governmental restrictions on its use.
Registrations in the U.S. for 2,4-D and 2,4,5-T in the 1940s
included many food crops and the use of these herbicides
increased to 17 million kg annually by 1960. Between 1966-
1969, over 62 million acres of U.S. agricultural land was
sprayed with these herbicides (IARC, 1986). In the late 1980s,
an estimated 75% of total usage of 2,4-D has been in control of
weeds in wheat and corn fields. Other use include weed control
in forests, right-of-ways, rangelands, parks and golf courses, and
home lawn and gardens and aquatic weed control (Ibrahim et al.,
1991). While the primary use of 2,4-D is as an herbicide, it has
minor uses as a growth regulator in prevention of premature
dropping of fruit and for the color enhancement of potatoes
(Munro et al., 1992).
B. Usage:
1. Agricultural Use:
2,4-D ranked fourth among the most used herbicides in
agriculture in the U.S. during 1990-93. During this time, 2,4-D
use for agricultural purposes on cropland was 41,938,492 lbs of
active ingredient (AI) per year (yr) (Gianessi and Anderson,
1995b). 2,4-D was the seventh most used herbicide in New
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York State (NYS), with 141,665 lbs of AI used annually on
croplands during 1990-93 (Gianessi and Anderson, 1995a).
2. Non-Cropland Use:
The U.S. Environmental Protection Agency (EPA) estimates
that the amount of 2,4-D used nation-wide on non-cropland
during 1987 was 12.6 to 28.7 million lbs of AI /yr (Gianessi,
1991).
III. Current Regulatory Status:
A. Regulatory Status:
1. 2,4,5-T:
Because of concerns about carcinogenicity, fetotoxicity, and
developmental toxicity, all registrations for 2,4,5-T were
canceled by the EPA in 1983 (USEPA, 1996; IARC, 1986).
2. 2,4-D:
A concern was raised regarding the possible carcinogenic role of
2,4-D in a case-control study done in Sweden in the late 1970s
(Hardell and Sandstrom, 1979). EPA called for more studies to
be done on 2,4-D and announced its intention to publicly
review the scientific literature related to 2,4-D (Munro et al.,
1992). 2,4-D is currently in Òpre-Special Review StatusÓ. This
term defines Òchemicals for which it is public knowledge that
they are being considered for formal Special ReviewÓ (USEPA,
1996). While more studies are being done in response to EPA
recommendation, the Industry Task Force (ITF) on 2,4-D
Research Data has agreed to a subset of recommendations from
EPA for risk reduction measures in September, 1992. These
include a plan to implement a user education program as well as
to reduce exposure through modifications to technical and
manufacturing use labels (USEPA, 1996). Results of new
oncogenicity studies on experimental animals were presented to
the peer review committee for EPA in December 1995. A recent
report from the Carcinogenicity Peer Review Committee
(CPRC) for EPA has classified 2,4-D in group D, Ònot
classifiable as to human carcinogenicityÓ (USEPA, 1997).
B. Workplace Regulations:
The U.S. Occupational Safety and Health Administration
(OSHA) has set the time weighted average (TWA) occupational
exposure limit for 2,4-D over an 8 hour workshift at 10 mg/m3
(IARC, 1986).
C. Drinking Water Standards and Health Advisories:
1. Maximum Contaminant Level:
The EPA has set the maximum contaminant level (MCL) for
2,4-D, to be no more than 0.07 mg/L in drinking water. MCL
is the maximum permissible level of a contaminant in water
which is delivered to any user of a public water system. This is
an enforceable limit on the maximum allowable concentration in
public water supplies.
2. Health Advisory:
Health Advisories (HA) are non-enforceable limits of the
concentration of the chemical in the drinking water that is not
expected to cause any adverse noncarcinogenic health effects
when consumed for no more than the time period specified, with
a margin of safety (USEPA, 1996). HA levels for drinking water
are as follows (USEPA, 1996):
10 kg child
· One day  = 1 mg/L
· Ten day = 0.3 mg/L
· Longer term = 0.1 mg/L
70 kg adult
· Longer term = 0.4 mg/L
· Lifetime = 0.07 mg/L
D. Food Residue Tolerances:
The past food residue tolerances for 2,4-D set by the federal
agencies in 1989 included tolerance levels of 0.2 ppm in peaches
and potatoes, and 0.5 ppm in grapes and 5 ppm in apples and
grapefruit (USDA, 1993).
IV. Summary of Evidence of Overall
Carcinogenicity; Non-Breast Sites
A. Human Studies:
Cancer risks from occupational exposures to chlorophenoxy
herbicides have been extensively reviewed in an International
Agency for Research on Cancer (IARC) monograph (IARC,
1986). IARC concluded that: ÒThere is limited evidence that
occupational exposures to chlorophenoxy herbicides are
carcinogenic to humans.Ó
Most studies have evaluated the risks due to exposures to
multiple herbicides and contaminating dioxins, and not to 2,4-
D alone. In this section, we have presented commentary on large
scale studies on cancer risks associated with 2,4-D exposure and
have summarized other studies assessing cancer risk involving
exposure to phenoxyacid herbicides (PH) and other pesticides.
1. Case Reports:
Although case-reports alone are inadequate to infer a causal
relationship for the carcinogenicity of chemicals, they provide
useful information to justify the need for further epidemiological
studies.
Three cases of soft-tissue sarcomas have been reported among
U.S. veterans who were exposed to Agent Orange. One of the
veterans with soft tissue sarcoma had been completely soaked in
Agent Orange two times (Sarma and Jacobs, 1982). Another
case report documented soft tissue sarcoma in a father and son
who were both employed at a chlorinated phenol manufacturing
plant and may have been exposed to 2,4-D, 2,4,5-T, chlorinated
phenols and organic solvents (Johnson et al., 1981). Two other
case reports suggest increased incidences of liver cancers among
patients in Vietnam hospitals who had been exposed to Agent
Orange (Ton That Tung, 1973, reviewed by Sterling and
Arundel, 1986; Van, 1984). In another study, four out of the five
patients that had cutaneous lesions due to non-HodgkinÕs
lymphoma (NHL) were reported to have repeatedly sprayed large
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areas with chlorophenoxy herbicides (Olsson and Brandt, 1981).
Another case report describes acute lymphoblastic leukemia in a
patient who had been employed by a lawncare firm for three
years during which he was exposed to chlordane, 2,4-D,
diazinon and BanvelÒ D, as well as organic solvents (Infante et
al., 1978).
No conclusions can be drawn about cancer risks due to 2,4-D
exposures from any of the case reports since the exposures were
to many different herbicides and their contaminants, and, in
some cases to many explosive and other war chemicals known
to be toxic.
2. Occupational Cohort Studies:
a) Manufacturing and Agricultural Workers
There are many cohort studies that have evaluated cancer
mortality in association with PH exposures, but only one study
included a population exposed to 2,4-D. A study of 878
employees (gender not specified for cohort, control group was
male) who had been engaged in the formulation, manufacture, or
packaging of 2,4-D and other PH at a Dow Chemical Plant,
Midland, MI, reported an overall non-significant increase in
deaths from malignant neoplasms. There was a significant
excess in the standardized mortality ratio (SMR = ratio of
observed to expected deaths multiplied by 100) of lymphatic
and haematopoietic cancers (SMR = 3.12, p < 0.05); cancers of
Ôother and unspecified sitesÕ (SMR = 3.88, p < 0.05); and non-
significant excess in mortality from cancer of the large intestine,
HodgkinÕs disease (HD), leukemia and aleukemia. No deaths
were reported from brain neoplasms (Bond et al., 1988). An
investigation into the cause of the observed increase in Ôother
and unspecified sitesÕ revealed that faulty reporting practices by
physicians of the area may have contributed to the observed
increase in mortality rates (Bond et al., 1990). The strength of
this study was that TWA for exposure to 2,4-D were available.
After four additional years, there were no new deaths from NHL
in this cohort, but the cohort continued to have a significant
excess in mortality from cancers of Ôother and unspecified sitesÕ
(SMR = 3.51) (Bloemen et al., 1993). However, only a small
numbers of deaths were expected in the four year period with a
74% chance of not seeing a single death from NHL (Blair and
Hoar Zahm, 1995). The limitations of the initial study of the
cohort and its follow-up were the small number of deaths, the
potential for co-exposure to 2,4,5-T and the lack of information
on the sites and specific nature of the cancers found to be
increased. It is not known if there were any women in the cohort
and if they were followed for cancer incidences. This cohort is
the only one known to have been exposed primarily to 2,4-D,
and it is important that it be followed to assess future cancer
deaths.
A study of 69,513 male farmers in Saskatchewan (Canada)
reports a trend for increased mortality due to NHL with greater
acreage sprayed with herbicides (p = 0.064 for the trend) (Wigle
et al., 1990). 2,4-D was the major herbicide used in this region.
Data on direct exposure to pesticides was not available, but
exposure was linked to number of acres sprayed for control of
weeds. The farmers did use a variety of other pesticides and
organic solvents that may have also contributed to the observed
increased risk.
Other cohorts have been evaluated for the risks due to PH
exposures but not to 2,4-D specifically. Incidence of cancer in a
Danish cohort of 690 male and 250 female workers assigned to
PH manufacturing and packaging operations was compared to
the cancer rate in the general population (Lynge, 1985).
Allowing for a 10 year-latency period, there was a significant
increase in relative risk (RR) for soft tissue sarcoma (RR = 3.67)
and rectal cancers (RR = 4.08) among male workers, and
cervical cancers (RR = 4.71) among female workers. However,
all the increased RRs were based on very small numbers (four
cases of each cancer type) and the main PH involved were 2-
methyl-4-chlorophenoxyacetic (MCPA) and 2,4,5-T. Another
study evaluated the number of deaths from soft tissue sarcoma
that were reported for an international cohort of 18,910 PH
production workers (including 1,527 women). The increase in
number of deaths was statistically significant (SMR = 6.06,
p<0.05) after allowing for a 10 to 19 year latency period, based
on four deaths. Data on duration of exposure were available for
this cohort (Saracci et al., 1991). Although there was exposure
to multiple chemicals, these two cohorts are important for future
follow-up studies on associations with PH exposures since they
include women.
A cohort study of 1,658 male German agricultural workers that
had the potential for exposure to a variety of pesticides including
2,4-D reported a two-fold increase in deaths due to bronchial
carcinoma (p< 0.05). The smoking habits of this cohort were
not found to be different from the general male German
population. Data on the number of years of employment in
agricultural work were available, but no attempt was made to
assess exposures to the different pesticides (Barthel, 1981). An
abstract from a study of a cohort of 33,669 pesticide applicators
in Florida, reported a significant increase (p values not stated) in
testicular (SMR 2.49) and prostrate (SMR 1.92) cancers among
male workers; cervical cancer among women applicators (SMR
3.71); but no cases of soft tissue sarcoma or NHL (Fleming et
al., 1997). Besides PH, this cohort also had the potential for
exposure to a wide variety of organochlorine and other
pesticides. Details of this study are not available.
A small cohort of 618 white male golf course superintendents
has been evaluated for cancer-related deaths (Kross et al., 1994).
A significant increase (p values not stated) in proportional
mortality ratio (PMR = number of deaths in the cohort
compared to the expected number of deaths in the general
population) was observed for all cancers in general (PMR =
1.36). Significantly elevated PMRs (p values not stated) were
also reported for lung cancer (PMR = 1.27), NHL (PMR =
2.11), brain cancer (PMR = 2.42), large intestinal cancer (PMR
= 1.78) and prostrate cancer (PMR = 2.29). In some golf
courses, 2,4-D was the most common herbicide used.
Confounding factors such as tobacco use and diet of the cohort
were not controlled for in this study. This study raises a concern
about the combined exposure of turfcare workers to various
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pesticides (herbicides, fungicides, insecticides) and tobacco
smoke and suggests a need for more carefully controlled case-
control studies of cancer incidences among those involved in
turfcare. However, it does not provide causal evidence for the
carcinogenicity of 2,4-D.
Other studies have not found a relationship between 2,4-D
exposure and increased cancer mortality. A study of a cohort of
20,245 pesticide applicators (99% males, 1% female) in Sweden
reported a non-significant increase in risk for HodgkinÕs disease
(HD) (RR 1.2) and no increased risk for NHL (Wiklund et al.,
1987a). This study lacked information on 2,4-D exposure
levels. A cohort of 2,239 male PH manufacturing workers in
England had a non-significant increase in mortality from NHL
(SMR = 2.3), based on only 2 deaths (Coggon et al., 1991). A
study of 1,971 male Finnish applicators did not find a
statistically significant association between any cancer and
exposure to chlorophenoxy herbicides (2:1 mixture of 2,4-D and
2,4,5-T) (Riihimki et al., 1982; Riihimki et al., 1983). A ten
year follow up of this cohort reported no increased cancer
mortalities, and no deaths from NHL or soft tissue sarcoma (Asp
et al., 1994). No deaths were seen due to soft tissue sarcoma and
NHL in a cohort of 1,222 male forestry workers of Ontario
(Canada) exposed to PH (Green, 1991).
b) Summary, Occupational Cohort Studies:
A cohort of 878 employees of a manufacturing plant who had
been exposed primarily to 2,4-D had increased incidences of
lymphatic and haematopoietic cancers, and cancers of Ôother and
unspecifiedÕ sites (Bond et al., 1988; Bloeman et al., 1990).
Further follow-up with better investigation of cancer types
should be done on this cohort.
Higher risk of cancer incidences or mortalities that were
associated with PH exposures in two or more studies, are soft
tissue sarcomas (Lynge, 1985; Saracci et al., 1991), NHL
(Coggon et al., 1991; Kross et al., 1994; Wigle et al., 1990)
and cervical cancers (Fleming et al., 1997; Lynge, 1985). In
contrast, other studies of applicators, manufacturing and forestry
workers have not observed a significant association between PH
exposures and increased cancer mortalities (Wiklund et al.,
1987a; Riihimaki et al., 1982; Riihimaki et al., 1983; Asp et
al., 1994; Green et al., 1991). All of the cohorts were exposed
to many chemicals including 2,4-D, and an association between
2,4-D exposures and cancer types cannot be established based on
these studies.
3. Population-Based Case-Control Studies
a) Non-HodgkinÕs Lymphoma:
About one half of the case-control studies have observed an
increased risk for NHL in association with 2,4-D and PH
exposures. A large scale case-control study evaluated 200 cases
of NHL (from the cancer registry for the state of Kansas) and 600
controls from the general population, matched for age and vital
status (all males). An increased risk for NHL (OR = 2.6, p value
not stated) was observed to be associated with farm use of 2,4-
D. There was a trend for increased risk for NHL with more
frequent use of 2,4-D (³ 21 days/year, p < 0.0001 for trend);
increased years of 2,4-D use (³ 26 years, p < 0.0002 for trend);
and time elapsed since first year of use (p < 0.0002 for trend)
(Hoar et al., 1986). The OR for herbicide use without protective
equipment (OR = 2.1) was higher than the OR for use with
protective equipment (OR = 1.5).
Another case-control study evaluated 201 cases of NHL among
farmers, identified through the Nebraska Lymphoma Study
Group and area hospitals and 725 controls that were matched for
age, sex and vital status. An elevated risk for NHL for men was
reported among farmers who mixed or applied 2,4-D (OR = 1.5;
95% CI 0.9-2.5; p value not stated). A trend for increased risk
for NHL was observed with more frequent handling of 2,4-D (³
21, p = 0.051 for trend). Surprisingly, a small, non-significant
elevation in risk (OR = 1.7) was found for men who used
protective equipment in comparison to workers who did not
(OR = 1.2) (Zahm et al., 1990). The data from the above two
case-control studies was pooled together and re-evaluated for
NHL risk (Weisenburger et al., 1991; Weisenburger, 1990).
The risk of NHL was observed to be elevated four-fold in men
who were exposed to 2,4-D more than 20 days / yr
(Weisenburger et al., 1991; Weisenburger, 1990).
A re-evaluation of 105 NHL cases (all male, from the
Department of Oncology, Umea, Sweden) and 335 controls
(matched for age, sex and vital status, selected from the National
Population Registry) reported a significantly elevated odds ratio
(OR = 5.5; p value not stated) for NHL associated with
exposure to a commercial mixture of 2,4-D and 2,4,5-T (Hardell
et al., 1994). Among four people who had been exposed to 2,4-
D alone (3 cases and 1 control), the risk was even higher (OR =
13) (Hardell et al., 1994). This re-evaluation confirmed the
previously reports of an increased risk for NHL in this
population (Hardell, 1981; Hardell et al., 1981). This study is
limited by the small number of cases that were exposed to 2,4-
D.
A case-control study of 181 NHL cases (from the regional
Cancer Surveillance System) and 196 random cancer-free
controls in western Washington found an increased risk for NHL
among male farmer workers exposed to organic solvents (OR =
1.74; p < 0.05). A logistic regression analysis was used to
determine if the increased risk was due to joint exposures with
PH. Farmers who reported exposures to PH and organic
solvents had a significantly elevated risk (OR = 1.5) over
farmers who had exposure to neither agent (Woods and Polissar,
1989). The risks associated with organic solvents and PH alone
were OR = 1.12 and OR  = 0.85, respectively. Since the
information on co-exposures to other chemicals besides the
combination of PH and organic solvents was lacking, it cannot
be determined if the increased risk observed was due to a specific
synergistic relationship, or a general higher use of different farm
chemicals.
A two-fold increase in incidence rates of NHL was reported
among males living in a rice-growing area of Italy where 2,4-D
and 2,4,5-T were used (RR = 2.2; 95% CI 1.4-3.5; p value not
stated) (Vineis et al., 1991). This population-based study was
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limited by small numbers (30 cases) and the lack of any
information about PH exposure.
Other studies have not observed a significant increase in risk for
NHL associated with 2,4-D and PH exposure. A population-
based case-control study evaluated newly diagnosed cases of
NHL (n = 115, all male) in Iowa and Minnesota and 227
controls from the states matched for age and vital status. The
OR was slightly, but not significantly increased among farmers
who had ever used 2,4-D (OR = 1.2; 95% CI 0.9-1.6) (Cantor
et al., 1993; Cantor et al., 1992). Agricultural PH use was
associated with a non-significant increase in risk (OR = 1.4, p =
0.26) in a study of 83 NHL cases (all males, New Zealand
Cancer Registry) and 168 controls with cancers at other sites
(Pearce, 1989; Pearce et al., 1986). The use of controls who had
other cancers is inappropriate as it may mask exposure-related
associations for chemicals that cause an increase in incidence of
different cancers.
In a population-based case-control study, the risk for NHL
among women agricultural workers from the eastern Nebraska
(119 cases and 471 controls) who had been exposed to PH, was
found to be not significantly different from controls (based on a
small number of subjects) (Zahm and Babitt, 1993). A nested
case-control study of 32 cases of lymphoma (31 males and 1
female) from an international cohort of pesticide applicators and
production workers did not reveal a significant increased risk for
NHL in association with PH exposure (Kogevinas et al., 1995).
The conflicting results of different studies and the lack of data on
2,4-D exposure history make an assessment of risk for NHL due
to 2,4-D difficult. An increased risk with no protective clothing
or with increased number of years of exposure is not always seen
in the studies indicating a positive association, as would be
predicted if 2,4-D was the causative agent (Zahm et al., 1990).
Two other considerations need to be made while evaluating the
results of the above studies: 2,4-D preparations were often
contaminated with dioxins before 1975 (Johnson et al., 1992),
and while one study found the use of surrogate or proxy
interviews to be satisfactory in assessing exposures (Brown et
al., 1991), such a practice has been found to cause an increased
recall-bias by another study (Olsen and Bodner, 1996). The
positive association found between NHL and joint exposures to
PH and organic solvents (Woods and Polissar, 1989) needs
further evaluation.
b) Soft-Tissue Sarcoma
Studies conducted on the association of PH exposure and
incidence of soft tissue sarcoma have also given inconsistent
results. Two out of the 11 studies reported a statistically
significant association for soft tissue sarcoma and exposure to
PH. These studies are summarized below.
A case-control study in Sweden that evaluated 46 cases and 201
controls found an increase in soft tissue sarcoma incidence
associated with PH exposure (RR = 5.3; 95% CI 2.4-11.5,
p<0.001) (Hardell and Sandstrom, 1979). A later study
interviewed 110 cases and 220 referents and reported a
significantly increased risk for soft tissue sarcoma (RR = 6.8;
95% CI 2.6-17.3, p value not stated) associated with exposure
to PH, based on 14 cases and 5 controls (Eriksson et al., 1981).
Exposure estimates were from interviews and may have been
affected by recall bias.
A small case-control study in Northern Italy reported a higher
risk of soft tissue sarcoma among women rice field workers who
were exposed to PH (OR = 2.7; 90% CI 0.59-12.37), based on
4 cases and 5 referents (Vineis et al., 1986). This study had
limitations, including the small sample size and the lack of
information on PH exposure levels. A study of 42 male cases
reported a significantly increased risk (RR = 1.7; p = 0.05) of
soft tissue sarcoma among farmers, farm managers and gardeners
(Balarajan and Acheson, 1984). Although often cited, this study
is of limited value since no attempt was made to assess
exposures to PH.
In contrast, other studies have found no increase, or a slight,
non-significant increase in risk of soft tissue sarcoma associated
with PH use. These include a study of 133 white men
diagnosed with soft tissue sarcoma and 948 matched controls in
Kansas reported no increased risk for soft tissue sarcoma
associated with farming (OR = 1.0) (Hoar et al., 1986). A case-
control population in New Zealand of 82 male cases of soft
tissue sarcoma and 92 male controls who had other cancers had
a small, non-significant increase in risk of soft tissue sarcoma
associated with PH exposure (OR = 1.3, p < 0.35) (Smith et
al., 1983; Smith et al., 1984). Another case-control study of
128 male soft tissue sarcoma cases and 694 cancer free controls
in western Washington State reports no association of soft tissue
sarcoma with PH exposures (Woods et al., 1987). A study of
354,620 male forestry and agricultural workers did not show an
association of soft tissue sarcoma and exposure to PH (Wiklund
and Holm, 1986; Wiklund et al., 1987b). No association
between soft tissue sarcoma incidences and service in Vietnam
was observed by Vietnam veteranÕs health studies (Greenwald et
al., 1984; Kang et al., 1986; Lawrence et al., 1985), but there
have been two case reports that were mentioned earlier (Sarma
and Jacobs, 1982; Johnson et al., 1981).
c) Vietnam Veterans:
Studies that have evaluated the cancer risks associated with
chemical exposures during the Vietnam conflict have been
reviewed extensively (IARC, 1987; IARC, 1986; Lathrop,
1988; Sterling and Arundel, 1986; Tindall, 1985; VAO, 1996).
Since the Vietnam veterans were exposed to complex herbicide
mixtures, as well as to other war chemicals and not to 2,4-D
alone, these studies do not further our understanding of the
cancer risk specifically due to 2,4-D and have not been included
here.
4. Summary of Human Studies on Carcinogenicity at Non-
Breast Sites:
In summary, due to inconsistent results of different
epidemiological studies, and exposure to multiple chemicals in
many studies, no clear association can be made for 2,4-D and
increased incidence of cancer in humans. Mortalities due to
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lymphopoeitic and cancers of ill-defined sites were increased in a
cohort exposed to 2,4-D (Bloemen et al., 1993; Bond et al.,
1988). Positive association for NHL has been observed in large
case-control studies that have evaluated 2,4-D exposures alone
(Hardell et al., 1994; Hoar et al., 1986; Zahm et al., 1990).
However, no association for NHL was observed in other case-
control studies following 2,4-D exposure (Cantor et al., 1992;
Woods et al., 1987) or PH exposures (Asp et al., 1994;
Fleming et al., 1997; Pearce et al., 1986).
The evidence for soft tissue sarcoma is even more limited since
none of the epidemiological studies have looked at 2,4-D
exposures alone. Some studies have indicated an increased risk
associated with PH exposure (Eriksson et al., 1981; Hardell and
Sandstrom, 1979; Lynge, 1985; Vineis et al., 1986) while
others have observed no association (Asp et al., 1994; Fleming
et al., 1997; Hoar et al., 1986; Smith et al., 1984; Woods et
al., 1987).
Very few studies have involved women. Increased incidence of
cervical cancers was reported for a cohort of women exposed to
PH in a chemical plant (Lynge, 1985) and a cohort of women
pesticide applicators (Fleming et al., 1997). Larger scale studies
on women cohorts exposed to 2,4-D are needed to determine if
2,4-D exposure affects cancer incidence or mortality in women.
B. Animal Experimental Studies:
All the cancer bioassays for 2,4-D conducted before 1986 had
limitations, and were considered inadequate by EPA (Ibrahim et
al., 1991). These cancer bioassays are often cited as evidence for
the carcinogenicity of 2,4-D in rodents. We have included them
here to point out their limitations.
1. Studies in Mice:
An unpublished oncogenicity study by the Bionetics Research
Labs, Inc. that reported a significant increase in reticulum cell
sarcomas in female mice was rejected by EPA due to the route of
administration used (subcutaneous injection) (Reuber, 1983). In
a follow-up study, the maximum tolerated dose (MTD = 100
mg/kg/day) of a commercial preparation of 2,4-D (purity not
specified), was administered by stomach tube to the C57BL/6
mice over 18 months. No increase in neoplasms was observed at
any site (Innes et al., 1969). Both the studies had limitations
since they used small number of animals (18/sex/strain), an
insufficient exposure time, and only one dose of 2,4-D.
Due to the limitations of the above studies, EPA recommended
that additional cancer bioassays be done. The Industrial Task
Force on 2,4-D Research (ITF) responded with a study in which
60 B6C3F1 mice of each sex, were fed 0, 1, 15 or 45 mg/kg/day
of 2,4-D in their diet for 2 years. No increase in tumor
incidences were observed in any of the groups of 2,4-D (97.5%
pure) treated mice (USEPA, 1997). EPA concluded that this
study should not be regarded as adequate evidence for no
carcinogenic effect of 2,4-D, because the highest dose used was
only half of the MTD (Ibrahim et al., 1991).
A new study was initiated, in which female B6C3F1 mice
(50/dose) were fed 0, 5, 150 or 300 mg/kg/day, and male mice
were fed 0, 5, 62.5 and 125 mg/kg/day of 2,4-D (96.4%) in diet
for 2 years. The MTD was reached since reduced body weight
gains were observed for males and females that were given the
highest dose. A non-significant increase in incidence of primary
hepatocellular adenomas was observed in treated female mice,
but the highest incidence was in the mice that had received the
lowest dose, indicating a lack of a dose response. This study
did not report a significant increase in any neoplasms in
response to 2,4-D ingestion (Charles et al., 1996a). This study
was considered to be a valid animal cancer bioassay by EPA
(USEPA, 1997).
2. Studies in Rats:
Weanling Osborne-Mendel rats (25 male and 25 female/dose)
were fed 0, 5, 125, 625 or 1,250 ppm of 2,4-D (96.7% purity)
in their diet for two years (Hansen et al., 1971). The original
report indicated a significant increase in the incidence of
malignant tumors (p < 0.05) in male rats that were fed the
highest dose and the tumors were not restricted to any specific
target organ (Hansen et al., 1971). A later study re-analyzed all
the histological sections that were available from this study
including sections from 6 animals/sex for the group fed the
highest dose, the controls, and any tumors that had been
sectioned (Reuber, 1983). Based on his re-analysis of the
histological sections that were available, Reuber reported an
increased incidence of lymphosarcomas in the 2,4-D treated male
and female rats (Reuber, 1983). These studies were limited by
the small number of animals, the low overall survival rates in
both the control and treated groups, especially since only the
surviving animals were examined for neoplasms (Reuber, 1983).
The 2,4-D oncogenicity studies conducted before 1986 (Hansen
et al., 1971; Hill and Carlisle, 1947; Innes et al., 1969; Reuber,
1983) were all found to be inadequate by EPA as they did not
meet the current bioassay guidelines. EPA recommended that
additional animal studies be conducted and two more recent
studies sponsored by the ITF are summarized below.
In an unpublished study reported to the EPA (USEPA, 1997),
Fischer 344 rats (60 rats/sex/dose) were fed 0, 1, 5, 15 and 45
mg /kg /day of 2,4-D (96.4%) for two years. A statistically
significantly increase in the incidence of certain brain tumors
(astrocytomas) was observed in male rats fed 45 mg/kg/day (p =
0.0026), while a non-significant increase was observed for male
rats fed 15 mg/kg/day. No brain tumors were observed in the
control or treated female rats. However Fischer rats in other
bioassays (although not specifically Fischer 344 rats) have been
shown to have highly variable frequencies of spontaneous brain
tumors, so the significance of the increased incidence of brain
tumors in the 2,4-D-treated male rats is unclear (USEPA, 1997).
There was a concern that the highest dose of 2,4-D used on rats
in this study was not at the MTD as evidenced by the lack of an
effect on food consumption.
Due to the concerns about low dose levels, another combined
toxicity /carcinogenicity study was initiated in which male and
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female Fischer 344 rats (50 of each sex per dose) were fed 2,4-D
(96.5%) at 0, 5, 75 or 150 mg/kg/day for 24 months. Ten
animals of each sex were sacrificed after 12 months of treatment
and evaluated for body weight, organ weight and
histopathology. This study did not find evidence of an increase
in brain astrocytomas, or any other neoplasms at doses of 2,4-D
that were higher than the previous study, indicating that the
results of the earlier study may have been due to the variable
rates of brain astrocytomas in Fischer rats (USEPA, 1997).
3. Studies in Dogs:
Three beagle dogs/sex were fed with either 0, 10, 50, 100, or
500 ppm of 2,4-D (96.7%) in diet for 2 years (Hansen et al.,
1971). No treatment-related neoplasms were observed in this
study. This study has been criticized for its short duration by
Reuber, who states that canine cancer bioassays should be
carried out for six years or longer (Reuber, 1983), and also for
the small sample size (Munro et al., 1992).
One veterinary hospital-based case-control study in dogs
reported an association between canine lymphoma and 2,4-D use
by the owner. Dogs who were exposed to lawns treated with
2,4-D had an increased odds ratio (OR) for canine malignant
lymphoma (OR = 1.3; 95% CI 1.04-1.67) (Hayes et al., 1991).
The OR was not increased for dogs whose owners did not use
2,4-D (controls), or for dogs who were not allowed into the
treated areas. Further, there was a significant trend (p < 0.02) for
increased risk for dogs with the more frequent use of 2,4-D by
the owners. The levels of exposure were assumed to be related
to the frequency of 2,4-D application. Although not ideal, this
exposure estimate should not invalidate this study, because
canine exposures to 2,4-D following lawn-treatments have been
documented in other studies (Arnold et al., 1991; Reynolds et
al., 1994). The study by Hayes and colleagues has been
criticized by Sternberg (Sternberg, 1992) and by a review by the
ITF, for the lack of information on exposure levels and the
possibility of a recall bias causing the weak positive association
observed (Carlo et al., 1992). Further animal studies are needed,
since the Hayes study reports some association between 2,4-D
exposures and a disease in dogs that resembles a disease also
observed in humans, in epidemiological studies. This study is
also important since it evaluates a possible association in
animals from ÒrealÓ exposures (more like the kind of exposures
that humans are likely to face), unlike cancer bioassays where
the animal are fed large doses of > 94% pure 2,4-D.
A one year chronic toxicity study in which 5 dogs/sex/group
were fed with 0, 1, 5 or 10 mg/kg/day of 2,4-D (96.7%) did not
report any immunotoxic effects but was too short to be regarded
as a carcinogenicity study (Charles et al., 1996c).
4. Studies in Sheep:
A study of small-intestinal adenocarcinomas in sheep showed a
positive association of the disease with PH use on some farms,
although other chemicals were also used and exposures to PH
were not documented (Newell et al., 1984).
5. Summary, Animal Studies:
In summary, animal studies on 2,4-D do not indicate a
consistent association between exposure and induction of site-
specific tumors, making it difficult to establish a causal
relationship. Studies in mice have not found 2,4-D to be
carcinogenic when fed in diet. Oral administration of 2,4-D was
associated with increased incidence of brain astrocytomas in
male rats (USEPA, 1997). Other studies in rats have not
observed a positive association between 2,4-D exposures and
any neoplasms (Charles et al., 1996b). All these animal studies
have used the oral route for administration of 2,4-D. Since the
greatest exposure to 2,4-D in humans occurs through dermal
absorption during application (Munro et al., 1992), the oral
administration of 2,4-D to animals does not accurately reflect
human exposures. One case-control study has reported an
increased incidence of canine lymphoma among 2,4-D exposed
dogs (Hayes et al., 1991). This association needs to be
evaluated further in a larger study with better exposure
assessment.
C. Current Classification of Carcinogenicity by Other
Agencies
1. IARC Classification:
IARC has determined that there is limited evidence in humans
for carcinogenicity of chlorophenoxy herbicides, including 2,4-
D. The evidence for carcinogenicity in animals has been
determined to be inadequate. Overall, the IARC has classified
2,4-D along with other chlorophenoxy herbicides in Group 2B
Òpossibly carcinogenic for humansÓ (IARC, 1987). Note that
this classification is based on a monograph published in 1987,
before many of the reports suggesting a link between 2,4-D
exposures and NHL were available.
2. NTP Classification:
Not classified.
3. EPA Classification:
The Health Effects Division of the Carcinogenicity Peer Review
Committee has concluded that 2,4-D should remain classified as
a Group D - ÒNot classifiable as to human carcinogenicityÓ. The
committee concluded that the evidence is inadequate and cannot
be interpreted as showing either the presence or absence of a
carcinogenic effect (USEPA, 1997).
V. Critical Evaluation of Breast Carcinogenicity
A. Human Studies:
1. Human Tissue Levels:
No reports were found on 2,4-D tissue levels in humans in
relation to breast cancer incidences. Traces of the persistent
contaminating dioxin, 2,3,7,8-TCDD, are still detectable in the
adipose tissues of hospitalized women in South Vietnam, who
were heavily exposed to Agent Orange, but not in women in
North Vietnam, where there was less war-time exposure
(Phuong et al., 1990). Breast cancer incidences were not
compared among women in the two regions, but a follow-up
study of the health consequences was recommended by the
authors (Phuong et al., 1990).
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2. Human Breast Milk Levels:
2,4-D does not persist or accumulate in the breast tissue or
breast fat. No studies were found that have reported its presence
in human milk.
3. Human Epidemiological Studies:
There are no case reports for breast cancer that implicated
exposure to 2,4-D. The few studies presented below have
evaluated the breast cancer incidences among cohorts that were
exposed to PH, including 2,4-D. Exposure to PH, including
2,4-D in these studies is not associated with an increase in
incidence of, or mortality from breast cancer.
Among the very few cohorts of women that have been evaluated
for PH exposures and cancer risk was a cohort of 1,069 female
workers employed at a PH manufacturing plant in Denmark. A
study of the employment records and the national cancer register
reported 13 cases of breast cancer and a RR of 0.9 for all women
who had worked in two PH plants. MCPA was the main
product of the plant but 2,4-D and 2,4,5-T were also produced,
and the probability for exposure to TCDD was low. The RR of
breast cancer was low (RR = 0.53) among women assigned to
the manufacturing and packaging of PH, and was based on only
two breast cancer cases (Lynge, 1985).
Only one death from breast cancer was reported after a 17-year
follow-up of an international cohort (IARC) of 1,527 women
herbicide applicators exposed to chlorophenoxy herbicides and
chlorophenols; a lower mortality rate than expected from breast
cancer. There was a non-significant increase in deaths from
breast cancer among males in this cohort (SMR = 3.5; 95% CI
42-1246; p values not stated), based on only two cases (Saracci
et al., 1991). A follow-up study of a subset of this cohort
comprising of 701 women occupationally exposed to
chlorophenoxy herbicides reported 7 incidents of breast cancer
and a standardized incidence ratio (SIR) of 0.9 (95% CI 0.4-1.9)
for breast cancer. The incidence of breast cancer was not
increased among women who were probably exposed to TCDD
(9 cases; SIR = 0.86); 8 of the cases of breast cancer were
diagnosed within 9 years since first exposure (Kogevinas et al.,
1993).
A study of a cohort of 50,682 female farmers (from the Swedish,
nation-wide, population-based, Cancer-Environment Register)
with exposures to pesticides and PH (mainly MCPA and
dichloroprop), did not report an increased incidence of breast
cancer (SIR = 0.83; 95% CI 0.78-0.88). The SIR did not
change between four different time periods of follow-up spanning
a total of 16 years (Wiklund and Dich, 1994).
Among 4,582 female Vietnam veteran, the RR for mortality due
to breast cancer was found to be non-significantly elevated (RR
1.23; 95% CI 0.62-2.47) when compared to 5,324 non-Vietnam
veteran women, based on 17 breast cancer cases (Thomas et al.,
1991). A follow up study observed no increase in risk of
mortality due to breast cancer (RR 1.03; 95% CI 0.6-1.78)
based on 26 cases among the Vietnam veterans (Dalager et al.,
1995). Confounding factors that were not controlled for included
smoking, reproductive history, alcohol use and occupational
exposure to pesticides since the war.
The studies that have been conducted thus far have several
limitations. All the studies were based on small cohort sizes in
which the exposure was not limited to 2,4-D and levels of
exposure to 2,4-D and other chemicals were not determined.
None of the studies controlled for other risk factors for breast
cancer, such as advancing age, early menarche, late menopause,
older age at first birth, alcohol, diet and family history of breast
cancer. Since breast cancer has a high survival rate,
epidemiological studies should evaluate breast cancer
incidences, rather than mortality, for a more accurate depiction of
possible effects due to 2,4-D exposures.
In summary, although the few studies done on the exposure of
women to PH and chlorophenoxy herbicides including 2,4-D
and breast cancer incidence or mortality do not indicate a
positive association, these studies are inadequate to evaluate the
effect of 2,4-D exposure on breast cancer risk. Large-scale studies
that are controlled for breast cancer risk factors are needed on
breast cancer incidences in women who were primarily exposed
to 2,4-D. If a large enough cohort with exposures primarily to
2,4-D is not available, better data on level and duration of 2,4-D
exposures is needed for the evaluation of a causal relationship.
B. Animal Studies:
The only animal study found to have reported an increase in
mammary neoplasms associated with exposures to 2,4-D had
many limitations and was declared invalid by EPA. The results
of this study have not been considered in our evaluation of the
breast carcinogenic potential of 2,4-D. The design and the
limitations of this study are presented below.
Groups of 25 Osborne-Mendel rats of each sex were fed 0, 5,
125, 625 or 1,250 ppm 2,4-D (96.7%) in diet for two years in a
study conducted by FDA (Hansen, 1971; unpublished report as
cited by Reuber, 1983). The combined incidence of benign
(fibroadenomas and adenomas) and malignant mammary tumors
(adenosarcomas) increased from 45% in control rats (fed no 2,4-
D), to 86% (p = 0.0064) in rats fed 25 ppm, and 63% (p =
0.0080) in rats fed 625 ppm, but was lower for rats fed 5 ppm
(40%) and rats fed 125 ppm (35%) (Hansen et al., 1971; as cited
by Reuber, 1983). Tissue sections from six animals per group
were analyzed histologically at the end of 2 years. A significant
dose-related trend was reported for the increase in mammary
neoplasms (p = 0.03), but a later re-evaluation of the
histological sections found that the dose-related trend for
mammary carcinomas (not including benign tumors) was not
statistically significant (p = 0.070) (Reuber, 1983). The increase
in the incidence of malignant mammary tumors reported in the
original report was modest, from 18% in the controls, to 28% in
female rats that were fed the highest dose of 1250 ppm; no
statistical evaluation was available (Hansen et al., 1971).
The limitations of this study include the small numbers of
animals (n = 25 females / dose), the high rate of sporadic
mammary lesions in the control group and the low survival
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rates (Reuber, 1983). The unavailability of the original report
and the inconsistency between the original report and its later
review make this study difficult to interpret. Other animal
studies on rats have not reported an increase in mammary
tumors with long term exposure to 2,4-D (Charles et al., 1996;
USEPA, 1997b). Therefore, there is inadequate evidence to
show that 2,4-D is a mammary carcinogen in experimental
animals.
Summary, Critical Evaluation on Breast Carcinogenicity:
Human epidemiological studies of women, who were exposed to
PH during its manufacture, as farmers or as Vietnam veterans
(Lynge, 1985) and women herbicide applicators who were
exposed to chlorophenoxy herbicides (Saracci et al., 1991) have
not reported a significant association between exposure to PH
and risk for breast cancer. These studies are inadequate to form a
conclusion on the breast cancer risk from 2,4-D exposure. The
studies were limited by the small sample sizes, not controlled
for breast cancer risk factors, and the women were exposed to
many chemicals in addition to 2,4-D. Large-scale studies, well
controlled for confounding factors that affect breast cancer risk
(such as age, reproductive history, diet and smoking alcohol
consumption), are needed on women who were exposed
primarily to 2,4-D. In the absence of large groups of women
available who were exposed primarily to 2,4-D, the studies
should evaluate women for whom the 2,4-D exposure data
(levels, duration) is available.
One study in animals has indicated an induction in mammary
neoplasms in rats that were fed 2,4-D over a long period of time
(Hansen et al., 1971). This study had severe limitations and
was not considered a valid bioassay by EPA. In addition to an
inadequate number of animals per dose and a low survival rate,
the results of this study were also questioned after a re-
evaluation of the histological sections (Reuber, 1983). Other
carefully controlled studies in animals have not reported an
increase in mammary tumors in response to long-term exposure
to 2,4-D (Charles et al., 1996a; USEPA, 1997).
C. Other Relevant Data on Breast Cancer Risk:
1. Oncogene Activation:
A study that analyzed the DNA from 28 canine lymphoma cases
(20 with known exposure to 2,4-D, 8 with no known exposure),
reported that exposure to 2,4-D was not associated with the
activation of C-N-ras, an oncogene-activating mutation that has
been detected in human lymphoma specimens (Edwards et al.,
1993).
2. Tests of Mutagenicity:
The mutagenicity of 2,4-D has been studied in humans who
were occupationally exposed to this pesticide, mammalian cells,
whole mammals, insects, bacteria and yeast. The results are
mostly negative or at best equivocal in every system studied.
a) Humans:
While some cytogenetic studies of the blood of individuals
occupationally exposed to 2,4-D reported no increase in
chromosome breaks and exchanges (Crossen et al., 1978;
Hogstedt et al., 1980; Linnainmaa, 1983; Mustonen et al.,
1986), others have reported an increase in chromosomal
aberrations in agricultural workers associated with the increased
seasonal herbicide use (Yoder et al., 1973). The study showing
the positive association had limitations. The results were highly
variable within controls, there was little statistical analysis, and
2,4-D was only one of the many pesticides used.
b) Mammalian Cells:
Purified 2,4-D free acid (99%) did not cause chromosomal
aberrations in human lymphocytes (Mustonen et al., 1986), or
DNA damage in human fibroblasts (Clausen et al., 1990).
However, a commercial formulation containing diethyamine salt
of 2,4-D was reported as causing chromosome breaks (Mustonen
et al., 1986). Another study reported that U 46 D Fluid (a
commercial preparation of 2,4-D and its dimethylammonium
salt) causes single-strand DNA breaks (Clausen et al., 1990). An
increased rate of sister chromatid exchanges (SCE) was observed
in cultured human lymphocytes treated with a commercial
sample of 2,4-D (free of dioxin contaminants), but the increase
was significant (p < 0.05) at only the lowest dose tested, and no
dose-response effect was observed (Turkula and Jalal, 1985).
Unscheduled DNA synthesis was induced in cultured human
fibroblasts by 2,4-D Fluid (2,4-D) (Ahmed et al., 1977). The
combined cytotoxic effect of U46 D Fluid and a common
agricultural residue, copper chloride (CuCl2), was evaluated on
fibroblast cells. A synergistic effect on induction of unscheduled
DNA synthesis and DNA repair was observed for cells that were
pre-treated with CuCl2 and then treated with U46 D Fluid
(Jacobi and Witte, 1991). No chromosomal effects were reported
for 2,4-D (purity not specified) treated bovine kidney cells
(Bongso and Basrur, 1973) or cultured murine fibroblasts
(Kolberg et al., 1970).
In summary, in vitro studies indicate that 2,4-D free acid does
not cause chromosome aberrations, but there is limited evidence
that commercial formulations containing 2,4-D and its amine
salts have some DNA-damaging potential. Since details on the
formulations used were not available, it is not clear from these
studies if the 2,4-D salts caused the DNA-damage. Due to the
variable accuracy and sensitivity of the different in vitro assays
to detect DNA damage, such assays should be used for screening
only, and the results verified in other systems.
c) Other Mammals:
In rats, a significant increase (p < 0.05) in chromosomal damage
(breaks) was reported in the bone marrow cella of animals that
were injected with 35 or 70 mg/kg of 2,4-D (purity not
specified) intraperitoneally (i.p.) (Adhikari and Grover, 1988),
but this route of administration does not accurately parallel
human exposures. Oral administration of 100 mg/kg 2,4-D
(99% purity) to male Wistar rats did not increase the frequency
of SCE in their lymphocytes (Mustonen et al., 1989). Dermal
application of 2,4-D (purity not specified) in mice did not
increase the frequency of micronuclei in the bone marrow cells of
treated animals, but tested positive in a genotoxic assay for
increased follicular nuclear aberrations (Schop et al., 1990).
 Cornell University Program on Breast Cancer and Environmental Risk Factors in New York State10
No induction in dominant lethal mutations was observed
following a single injection (i.p.) of 125 mg/kg of 2,4-D
(commercial formulatios) in male mice (Epstein et al., 1972). In
another study, bone marrow erythrocytes of mice injected with
100 mg/kg of 2,4-D (purity not specified, < 1ppm dioxin
content) did not show a detectable increase in micronuclei when
compared to untreated controls. However, gas chromatographic
analysis of cell and plasma fractions indicated a very low
penetrance of 2,4-D into the cells (Jenssen and Renberg, 1976).
The lack of permeability of 2,4-D seen in this study emphasizes
the need to evaluate the mutagenicity of 2,4-D under conditions
in which it can better penetrate the cell. A recent study has
indicated that lipophilic agents can increase the cell permeability
to 2,4-D (Witte et al., 1995). Experimental conditions
influencing the penetration of 2,4-D into the cell should be
evaluated.
d) Insects:
When tested on Drosophila, 10,000 ppm 2,4-D fed to larvae
was found to induce sex-linked recessive lethal mutations
(SLRL) (IARC, 1987; Kale et al., 1995). In adult Drosophila,
10,000 ppm 2,4-D (99%) was found to have no effect on SLRL
mutation rate by oral administration or by injection (USEPA,
1997; Zimmering et al., 1985).
e) Yeast and Bacteria:
The mutagenicity of pure 2,4-D was negative in the Ames test
for mutagens in Salmonella typhimurium and Escherichia coli
(IARC, 1987; Mortelmans et al., 1984; Nagy et al., 1975;
USEPA, 1997; Zetterberg et al., 1977). However, one study on
his mutants of S. typhimurium strain TA97a indicated a slight
mutagenic effect of 2,4-D (purity not specified), as seen by the
increased frequency of revertants (Kappas, 1988).
Two studies have found that experimental conditions such as
pH can influence the effects of 2,4-D. In yeast, a dose-dependent
increase in the frequency of mitotic gene conversion and
recombination was observed in Saccharomyces cerevisiae, in
response to a sodium salt of 2,4-D but only at low pH
conditions (pH 4.5) (Zetterberg et al., 1977). A pH dependence
for cell penetration and mutagenicity in yeast was suggested by
this study (Zetterberg et al., 1977). In another study, 2,4-D
(purity not specified) caused an increase in the rate of mitotic
segregation in the fungus Aspergillus nidulans, only when it
was administered along with the metabolic activating medium
S9; no increase was observed in the absence of the S9 activating
medium (Kappas, 1988).
f) Summary, Evidence for Mutagenicity:
The evidence for mutagenicity of 2,4-D is equivocal. There are
conflicting results in every system that has been used to test its
mutagenic potential. Lipophilic agents (Witte et al., 1995),
CuCl2 (Jacobi and Witte, 1991), and pH (Zetterberg et al.,
1977), may be affecting the penetration of 2,4-D and the
outcome of genotoxic assays. The influence of these factors on
2,4-D penetration of cells and its genotoxic effect, needs further
evaluation.
3. Evidence of Tumor Promotion:
CBA X C57/BL hybrid mice (100/group, sex not specified)
were painted on the skin with one drop of a 0.5% solution of the
carcinogen 3-methylcholanthrene (3-MCA) for three weeks,
followed by skin application of a 10% solution of the amine salt
of 2,4-D to one group. Mice that received 3-MCA alone or the
10% solution of 2,4-D amine had no papillomas, but 18% of the
mice that were applied with both 3-MCA and 2,4-D amine had
skin papillomas suggesting a weak skin tumor promotion effect
by 2,4-D amine (Arkhipov and Kozlova, 1974, translated by
Reuber, 1983).
In an Òinitiation-selection-promotionÓ study, 2,4-D (analytical
grade) was assayed for its ability to promote liver carcinogenesis
in male Wistar rats that were treated with diethylnitrosamine
(DEN), 2-acetylaminofluorine (2-AAF) and carbon tetrachloride
(CCl4) (Abdellatif et al., 1990). Groups of 7 to 12 animals were
injected with 200 mg/kg DEN (for initiation of tumors), fed
0.03% 2-AAF for two weeks during which time a single 2
ml/kg dose of CCl4 was given by gavage (for selection) followed
by a diet containing 0.05% 2,4-D for 23 weeks (to test for
promotion). Although a 2-fold increase in peroxisomal b-
oxidation of fatty acids was noticed in 2,4-D treated animals, no
incidence of liver tumors was reported in this study.
In another study, male CD-1 mice (25/group) were exposed to a
commercial formulation of 2,4-D (including 2,4-D amine) in
drinking water for 15 weeks, followed by a single administration
of urethan (1.5 mg/g, i.p.). Mice that had been treated with 2,4-
D had a moderate increase in number, but not size of urethan-
induced pulmonary adenomas, and no dose-response
relationship was observed (Blakley et al., 1992). In a similar
study female CD-1 mice (15/group) that were exposed to
TordonÒ 202C (a mixture of 2,4-D and picloram) in drinking
water were given one i.p. 1.5 mg/g dose of urethan. The
number, but not the size of pulmonary adenomas was
significantly increased (p =0.002) in animals that were
previously treated with TordonÒ 202c (Adams et al., 1991).
Authors suggest immunological impairment or metabolic factors
as possible mechanisms by which 2,4-D may be promoting
these lung adenomas.
4. Signal Transduction and Intercellular Communication:
Disruption of intercellular communication is one of the
suggested mechanisms leading to cell transformation. 2,4-D
(99% purity) was found to significantly inhibit (p < 0.05)
intercellular communication in Chinese hamster cells in vitro at
non-cytotoxic doses. Some additive effect of mixtures of 2,4,5-T
and 2,4-D were observed, although the effects were weaker than
the positive control 12-tetradecanoylphorbol-13-acetate (TPA)
(Rubinstein et al., 1984). 2,4-D should be tested for its ability
to disrupt intercellular communication in breast epithelial cells,
as a possible mechanism to affect breast cancer risk.
5. Effects on Hepatic Microsomal Hydroxylases:
Agents that act as peroxisome proliferators may induce
genotoxic effects due to increased production of oxidative
enzymes. Increased hepatocellular carcinomas have been
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observed in association with peroxisome proliferation (Warren et
al., 1982). 2,4-D has been shown to induce hepatic fatty acid b-
oxidation and peroxisomal proliferation in rodents (Hietanen et
al., 1985; Kawashima et al., 1984; Mustonen et al., 1989;
Vainio et al., 1983) and a hepatic peroxisome proliferation effect
in rat Leydig cells (Liu et al., 1996). Daily gastric intubations
of 50, 100 and 200 mg/kg of 2,4-D (analytical grade) for three
days induced hepatic enzymes such as the P450 IVA1
monooxygenase in male Wistar albino rats (Bacher and Gibson,
1988).
2,4-D may act as a tumor promoter by inducing peroxisome
proliferation and oxidative enzymes in the liver. It has not been
tested in animals for its tumor promotion effect in the mammary
gland.
6. Immunological Effects:
A compromised immune system may affect host defenses against
cancer.  There is some evidence that suggests that exposure to
2,4-D may compromise the immune response of exposed
humans.
Commercial formulations of 2,4-D and MCPA were found to
exert short-term immunosuppressive effects in a group of 10
male farmers that were evaluated before and after exposure. A
significant reduction was found one to 12 days following
exposure (p < 0.05) in the circulating helper (CD4), suppressor
T cells (CD8), CD8 dim, CD8 cells expressing surface antigen
HLA-DR (CD8-DR), cytotoxic T lymphocytes (CTL), and
natural killer cells (NK). The mitogenic responses of
lymphocytes (to concanavalin A and phytohaemagglutinin) one
to twelve days after exposure were significantly lower (p < 0.01)
than the mitogenic responses before exposure. After 50 to 70
days, other immunological values were comparable to controls,
but the mitogenic proliferative responses were still significantly
decreased (p < 0.05) (Faustini et al., 1996). The CTL and NK
cells are involved in the cytolysis of virally infected cells and in
cell mediated immunity to tumors; these immune changes could
have health implications, and possibly affect cancer risk
(Faustini et al., 1996).
Female offspring of CD-1 mice that were exposed in utero to n-
butylester of 2,4-D, had a non-significant reduction in
lymphocyte proliferative response to mitogens (Blakely and
Blakely, 1986). However, adult female BDF1 mice that were fed
n-butylester of 2,4-D had a slightly increased lymphocyte
proliferative response to mitogens following exposures (Blakely,
1986).
We conclude that there is very limited evidence from one study
in humans that 2,4-D may compromise the immune system
(Faustini et al., 1996). This study had limitations. It studied a
small number of farmers who were exposed to 2,4-D and many
other chemicals. However, the observation of reduced mitogenic
response of lymphocytes in exposed farmers (Faustini et al.,
1996) needs to be evaluated in a larger study and over longer
periods of time. Epidemiological studies on cancer incidences in
farmers, applicators or manufacturing workers exposed to 2,4-D
should include an evaluation of the immune system. The animal
studies conducted so far are inadequate to determine if 2,4-D
exposures can damage the immune system. More studies are
needed to determine if adult and in utero exposures to 2,4-D can
compromise the immune response. If immune-suppression is
observed, the experimental animals should be challenged with
mammary tumors cells to evaluate if the immune-suppression
affects breast cancer risk.
7. Evidence of Endocrine Disruption:
a) Leydig Cells
In one study, isolated rat Leydig cells that were treated with
2,4-D were found to release significantly more estradiol into the
medium. The response to 2,4-D was similar to the response to
other chemical peroxisome proliferators that have been
implicated in the formation of Leydig cell tumors in vivo  (Liu
et al., 1996). However, 2,4-D reduced the non-stimulated release
of testosterone, an effect that was unlike most peroxisome
proliferators and tumor promoters. This study suggests that 2,4-
D can affect the steroidogenic function of Leydig cells in vitro. It
does not provide adequate evidence to suggest that 2,4-D may
act as a Leydig tumor promoter or for endocrine disruption in
vivo.
b) Estrous Cycle:
The estrous cycle is the reproductive cycle in rodents that is
regulated by ovarian and gonadotropic hormones. In a study that
has been presented only as an abstract, injection of 2,4-D at
doses of 1 mg/kg/day and 12 mg/ kg/day into female rats over a
period of two months was reported to cause a prolonged diestrus
phase and changes in the duration of estrus and metaestrus (Vin
et al., 1990). This study does not provide adequate evidence to
indicate that 2,4-D causes endocrine disruption or affects the
reproductive cycles in rats since details of analysis were not
presented. No other studies were found to have analyzed 2,4-D
for endocrine disruption in vivo.
c) Estrogenicity:
2,4-D does not appear to be estrogenic, as determined by its
inablity to stimulate proliferation of MCF-7 cells (an estrogen-
dependent breast tumor cell line) in the E-SCREEN assay for
estrogenicity (Soto et al., 1995). E-SCREEN test is an in vitro
screen for estrogenicity and does not provide conclusive negative
evidence on the in vivo estrogenic potential of 2,4-D.
d) Effects on Growth Factors :
A published abstract reports that 2,4-D stimulates the
production of transforming growth factor-beta (TGF-b) from
MCF-7 human breast tumor cells (Lorick et al., 1995). TGF-b
is known to inhibit the growth of normal human breast
epithelial cells and estrogen receptor (ER) negative breast cancer
cells, but not ER positive breast cancer cells. The complete role
of TGF-b in mammary gland development and tumorigenesis is
not well understood (Koli and Arteaga, 1996). Therefore, we
cannot conclude whether the 2,4-D mediated induction of TGF-
b in MCF-7 cells reflects a potential for in vivo effects on
mammary gland growth and thus breast cancer risk.
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e) Summary, Endocrine Disruption:
While 2,4-D is not estrogenic, as determined by an in vitro
screen for xenoestrogens (Soto et al., 1995), it can modify
steroidogenesis in rat Leydig cells (Liu et al., 1996) and there is
very limited evidence from a published abstract that it may
disrupt the length of reproductive cycles in rats (Vin et al.,
1990). The cause for the delay in estrous cycle progression in
animals by 2,4-D needs further evaluation.
8. Reproductive Effects:
Reproductive toxicity may be suggestive of either endocrine
disruption or embryo toxic effects.
Reproductive effects were studied in (20 female and 10
male/dose) Osborne-Mendel rats that were fed 0, 100, 500 and
1500 ppm 2,4-D over three successive generations. No
deleterious effects were observed on litter size (for 6 litters
produced), but the survival time and weight of the weanlings
was decreased (Hansen et al., 1971). These effects of 2,4-D do
not indicate reproductive toxicity in response to endocrine
disruption.
Animal studies on reproductive effects done so far do not
support the role of 2,4-D as an endocrine disruptor.
9. Summary of Other Relevant Data on Breast Cancer Risk:
The evidence for the mutagenicity of 2,4-D is equivocal in most
systems studied. 2,4-D was found to inhibit cell-cell
communication in some mammalian cells (Rubinstein et al.,
1984). There is limited evidence that 2,4-D may compromise
the human immune system (Faustini et al., 1996). There is
were two studies that have reported that 2,4-D acted as a lung
tumor promoter (Adams et al., 1991; Blakley et al., 1992) and a
weak skin tumor promoter (Reuber, 1983). Several studies have
shown peroxisome proliferation and an increase in oxidative
enzymes in the liver in response to 2,4-D, which may lead to
genotoxic effect through the production of oxygen free radicals
and a tumor promotion effect (Hietanen et al., 1985; Kawashima
et al., 1984; Liu et al., 1996; Mustonen et al., 1989; Vainio et
al., 1983). However, 2,4-D was not found to promote hepatic
tumors in rats (Abdellatif et al., 1990) 2,4-D was not estrogenic
in the in vitro E-SCREEN assay, (Soto et al., 1995). Although
one published abstract reported that 2,4-D delayed the estrus
cycle in female rats (Vin et al., 1990), a reproductive toxic effect
has not been shown for 2,4-D (Hansen et al., 1971).
VI. Other Relevant Information
A. Environmental Fate and Potential for Human
Exposure:
1. Environmental Fate:
2,4-D does nor persist in soil because of its rapid degradation.
The average persistence of its phytotoxic effect is detected for
one to four weeks in warm, moist soil. (WHO, 1989).
Dislodgeable residues of 2,4-D show a rapid decline from 8% in
the first hour following application to turf, to 1% after 24 hours
(Harris and Solomon, 1992).
2. Occupational Exposure:
The populations at most risk for occupational exposures today
are those who work in manufacturing plants, or as herbicide
applicators, forestry, agricultural, and turfcare workers. There is
a report on workers in container recycling operations getting
exposed to 2,4-D (Guidotti et al., 1994). The highest urinary
concentrations of 2,4-D (0.3 to 8 mg/L) have been reported from
ground-spraying operations in forestry work (IARC, 1986). A
mean urinary concentration of 1.37 mg/L was measured in
workers involved in the production and manufacture of 2,4-D
(IARC, 1986).
3. Sources of Exposure for the General Population:
Since 2,4-D does not persist in the environment or
bioaccumulate in animal fat, diet is not a major source of 2,4-D
exposure for the general population (WHO, 1984). Homeowners
who apply 2,4-D to their yards without protection may be
exposed. People who launder 2,4-D-contaminated clothing may
also be exposed to this chemical. In a study that attempted to
estimate the exposure of bystanders, volunteers were monitored
for exposure after controlled activities on recently sprayed turf
(Harris and Solomon, 1992). The levels of 2,4-D in urine
samples from most volunteers indicated that they had had very
low exposures. The highest exposure to 2,4-D was found in a
barefooted volunteer in shorts, who removed his shirt for 30
minutes during the exposure period (Harris and Solomon,
1992).
4. Absorption and Excretion:
During occupational exposure and application of 2,4-D, dermal
absorption is a major route of entry into the body. A study of
the urine concentrations of 2,4-D of occupationally exposed
sprayers indicated peak concentrations within the first three days
(Knopp and Glass, 1991). Absorption of 2,4-D by the human
body was rapid following oral administration and more than
80% of the dose was excreted unchanged in the urine of five
male volunteers who ingested the chemical (Sauerhoff et al.,
1977). No notable metabolic transformation of 2,4-D has been
detected (Lilienfeld and Gallo, 1989), and it is cleared from the
human body within 2 to 4 days (Munro et al., 1992).
Dermal absorption of 2,4-D in rats is dependent on the site of
application. 2,4-D has been shown to pass the placental barrier
in mice (Ulm and Springer, 1994), pigs and rats (Munro et al.,
1992).
VII. Summary and Recommendation for Breast
Carcinogenicity Classification
The evidence for 2,4-D causing breast cancer in humans and
animals is inadequate. There is very limited evidence of
possible mechanisms by which 2,4-D may affect breast cancer
risk. Until these mechanisms are studied further, 2,4-D should
be classified in Group 3, as not classifiable for its breast
carcinogenicity to humans (see Appendix B).  Our conclusions
are based on the following. In humans, the few studies
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published on women cohorts exposed to 2,4-D occupationally
have not demonstrated an increase in breast cancer incidence or
mortality. However, it should be noted that the available studies
are not of sufficient quality, number, or size to assess 2,4-DÕs
potential to be a breast carcinogen. In addition, these studies did
not adequately control for other breast cancer risk factors and the
cohorts were exposed to multiple pesticides and/or war
chemicals in addition to exposure to 2,4-D. In experimental
animals, studies have not demonstrated an induction of
mammary gland neoplasms with 2,4-D administration, with the
exception of one study that has been deemed invalid because of
inaccurate histological evaluation of tumors (Hansen et al.,
1971). There is very limited evidence that 2,4-D may have the
potential to affect breast cancer risk by other mechanisms.
There is inadequate evidence that 2,4-D may act in animals as a
weak tumor promoter for skin and for lung tumors (Adams et
al., 1991; Blakley et al., 1992; Reuber, 1983). 2,4-D was found
to inhibit intracellular communication in some mammalian cells
(Rubinstein et al., 1984) and induce hepatic enzymes, effects
that could contribute to tumor promotion (Bacher and Gibson,
1988; Hietanen et al., 1985; Kawashima et al., 1984; Vainio et
al., 1983). 2,4-D was determined to be non-estrogenic in the E-
SCREEN for xenoestrogens (Soto et al., 1995), but chronic
administration of 2,4-D was reported in one abstract to cause a
disruption in the length of the estrus cycle in female rats (Vin et
al., 1990). Further assays of the estrogenicity of 2,4-D are
required. There is some, but limited, evidence that recent
exposures to chemicals including 2,4-D may cause immune-
suppression in humans (Faustini et al., 1996).
Comment:
2,4-D is one of the few herbicides with large scale non-
agricultural use for weed control in homes and gardens and
recreactional areas. Unlike many other herbicides where
exposures are limited to those who mix and apply pesticides on
croplands, the potential for exposures to 2,4-D is more
widescale. Turfcare workers and homeowners, if they do not take
proper precautions when applying 2,4-D products, and to a
limited extent people who access treated areas too soon after
application of 2,4-D, can also be exposed to 2,4-D. While there
is no demonstrated evidence that 2,4-D is a human breast
carcinogen, as with any chemical, caution should be exerted in
its use, storage, and disposal.
VIII. Identification of Research Gaps, and Other
Recommendations
· Large-scale case-control studies are needed on the breast
cancer incidences in large populations of women who were
exposed primarily to 2,4-D. If the population to be studied
has been exposed to other chemicals, better data on level
and duration of 2,4-D exposures is needed for an evaluation
of a causal relationship.
· Lipophilic environmental contaminants (other pesticides
and their metabolites) may enhance the penetration of 2,4-D
into tissues and the cell. Animal assays for genotoxicity
should evaluate lipophilic agents that may accompany 2,4-
D exposures due to combined use, for their ability to
enhance any effects caused by 2,4-D.
· Animal studies are needed to evaluate 2,4-DÕs potential to
be a co-carcinogen and or a tumor promoter of known
mammary gland carcinogens such as 7, 12-
dimethylbenz[a]anthracene (DMBA) and N- nitroso-N -
methylurea (NMU).
 
Further animal studies are needed to determine if 2,4-D can
compromise the immune system. If an immune suppression
effect is observed, further studies would be warranted to
determine if the immune suppression affects the bodyÕs defense
against cancer. For an evaluation of breast cancer risk
specifically, studies would need to determine if animals exposed
to 2,4-D in utero, or as adults, and subsequently exposed to
transplantable mammary tumors cells, develop a higher
incidence of mammary tumors. Studies following populations
exposed to 2,4-D should include an assessment of immune
function, as well as cancer incidence, to determine if 2,4-D may
affect cancer risk by compromising immune function.
IX. Summary of New Human Studies Currently
Being Conducted
We have pointed out the need for more epidemiological studies
on cancer rates and immune-effects in populations that were
exposed to 2,4-D. Several ongoing / proposed studies on 2,4-D
effects were found in the CRISP Database (see Appendix A) and
are outlined below.
Herbicide Exposure Effect on Natural Killer Cells:
(PI: Ballas, Z.K., University of Iowa, extracted from the
CRISP Database FY 96)
A study will evaluate the effects of herbicide exposures among
agricultural workers, particularly on natural killer cells. The
hypothesis of this project is that 2,4-D increases the incidence of
immunologically-related cancers by inhibiting NK cells activity.
Studies of Occupational Cancer--Pesticides:
(Alavanja, M., Blair, A., NCI, NIH, extracted from the
CRISP Database, FY 97, and Personal Communication)
A large scale ÒAgricultural Health StudyÓ proposes to look at
the relationship between agricultural exposures and cancer risk.
Enrollment in this study includes 90,000 men and women
farmers, pesticide applicators and farmerÕs wives from Iowa and
North Carolina. Besides conducting interviews to determine
pesticide use, it will also seek information on lifestyle factors,
medical and family history of disease and diet.
MCPA-Probenecid Interaction with 2,4-D in Dogs:
(Gerken, D.F., Ohio State University, extracted from the
CRISP Database, FY 95)
2,4-D is generally used in combination with other
chlorophenoxy herbicides. A study will evaluate any synergistic
effects between 2-methyl-4-chlorophenoxyacetic acid (MCPA)
and 2,4-D in dogs. These two herbicides have similar
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absorption, distribution and excretion patterns, as well as the
same clinical toxicity symptoms.
Environmental Risk Factors for Lymphomas and
Sarcomas:
(Tolbert, P.E., Emory University, Atlanta, GA, extracted
from the CRISP Database, FY 97)
The investigators propose  to investigate patterns of risk in
subtypes and groupings of subtypes of non-Hodgkin's
lymphoma, a group of etiologically distinct diseases, that have
been so far studied as one. Environmental and occupational
exposures that have previously been reported to be associated
with all non-Hodgkin lymphomas combined (e.g., herbicides,
leather, meat, solvents, formaldehyde, asbestos, radiation,
EMF), will be reassessed for subtypes of NHL. Pooled analysis
combining data from previous, smaller case control studies will
be done. A similar approach is planned for studying sarcoma, a
second group of cancers included in the Selected Cancers Study.
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XI. Appendix A.  Common Abbreviations, Acronyms and Symbols
2-AAF 2-acetylaminofluorine
2,4-D 2,4-dichlorophenoxyacetic acid
2,4,5-T 2,4,5-trichlorophenoxyacetic acid
3-MCA 3-methylchlolanthrene
ADI Allowable Daily Intake, set by the World 
Health Organization
AI active ingredient
ATSDR Agency for Toxic Substances Disease 
Registry
BCERF Program on Breast Cancer and 
Environmental Risk Factors in New York 
State, based in theCornellÕs Center for the 
Environment, Institute of Comparative and 
Environmental Toxicology
bwt body weight
C carbon
CAS Chemical Abstract Service
CCl4 carbon tetrachloride
CfE Cornell UniversityÕs Center for the 
Environment
CI Confidence Interval
Cl chlorine
CPRC Carcinogenicity Peer Review Committee for 
EPA
CRISP Computer Retrieval of Information on 
Scientific Projects; database of scientific intra 
and extramural projects supported by the 
Dept. of Health and Human Services (i.e., 
NIH, EPA, USDA)
CTL cytotoxic T lymphocytes
DEN diethylnitrosamine; a carcinogen in the liver
DMBA 7,12-dimethylbenz[a]anthracene; known 
mammary carcinogen
DNA deoxyribonucleic acid
EPA U.S. Environmental Protection Agency
ER estrogen receptor
E-SCREEN screening assay for estrogenicity that 
measures proliferative response in estrogen-
dependent MCF-7 breast tumor cells
FDA Food and Drug Administration
HA Health advisories are non-enforceable limits 
of the concentration of the chemical in the 
drinking water that is not expected to cause 
any adverse noncarcinogenic health effects 
when consumed for no more than the time 
period specified, with a margin of safety
HD HodgkinÕs disease
IAA indoleacetic acid
IARC International Agency for Research on Cancer, 
headquartered in Lyon, France
ICET Institute for Comparative and Environmental 
Toxicology
i.p. interperitoneal
IRIS Integrated Risk Information System; 
Database maintained by EPA available 
through the National Library of Medicine 
MEDLARS system
ITF Industrial Task Force on 2,4-D Research
kg kilogram
L liter
LI Long Island, New York
mg microgram
m3 cubic meter
mg milligram
MCF-7 Michigan Cancer Foundation; cells derived 
from human breast tumor
MCL Maximum Contaminant Level; enforceable 
limit set by EPA which sets the maximum 
level of a contaminate in a public drinking 
water supply
MCPA 2-methyl-4-chlorophenoxyacetic
MTD maximum tolerated dose
n number of subjects/animals in the group
NA Not available
NHL non-HodgkinÕs lymphoma
NIOSH National Institute of Occupational Safety and 
Health
NCI National Cancer Institute
NIEHS National Institute of Environmental Health 
and Safety
NIH National Institutes of Health
NK natural killer cells
NMU N-nitroso-N-methyurea; mammary 
carcinogen
NRC National Research Council
NS Not statistically significant
NTIS National Technical Information Service; 
repository for federal agency technical reports
NTP National Toxicology Program
NY New York
NYS New York State
OR Odds Ratio
OSHA Occupational Safety and Health 
Administration
PH phenoxyacid herbicides
PMR Proportional Mortality Ratio; PMR = 
number of deaths in the cohort compared to 
the expected number of deaths in the general 
population
ppm parts per million
ppb parts per billion
RR Relative Risk
SCE sister chromatid exchanges
SIR Standardized Incidence Ratio; SIR= the ratio 
of ÒobservedÓ to expected incidences
SMR Standardized Mortality Ratio; SMR= the 
ratio of ÒobservedÓ to ÒexpectedÓ deaths
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TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin
TGF-b transforming growth factor-beta
TPA 12-tetradecanoylphorbol-13-acetate
TSH thyroid stimulating hormone
TWA Time-weighted average
U.S. United States
USDA United States Department of Agriculture
USEPA United States Environmental Protection 
Agency
WHO World Health Organization
Yr year
Symbols:
a alpha
b beta
g gamma
mg microgram
< less than
> greater than
% percent
p p value
+  plus or minus
= equal
¨ registered trademark
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XII Appendix B. Critical Evaluations of Breast Cancer Carcinogenicity
This includes an overview of the Critical Evaluations and explanation of the BCERF Breast Carcinogenicity Classification Scheme
The Process
Starting Point - Existing Critical Evaluations on Evidence of Carcinogenicity
IARC Monographs (International Agency for Research on Cancer)
NTP ARC (National Toxicology Program, Annual Report on Carcinogens)
ATSDR (Agency for Toxic Substances and Disease Registry)
Conduct Literature Searches using databases to obtain historical and the most recent information; i.e. Toxline, Medline, Biosis,
Cancerlit
· Peer-reviewed scientific literature-available through Cornell libraries and interlibrary loans.
· Technical Reports-NTIS-National Technical Information Service
· TOXNET databases--EPAÕs IRIS database source of oncogenicity and regulatory status information
· Grey literature--Studies submitted to EPA that are not published:
-Industry generated oncogenicity studies
-Some abstracts (short summaries) are on line (IRIS database)
-Request reports from industry
-Request reports from EPA through Freedom of Information Act
The critical evaluation will include some general background information, including chemical name, CAS#, trade name, history of
use, and current regulatory status.
Evidence of cancer in other (non-breast) organ systems will be provided in synopsis form with some critical commentary, along with
the current overall carcinogenicity classification by international (IARC) and U.S. Federal Agencies (NTP, EPA).
Human epidemiological studies, animal studies, and other relevant studies on possible mechanisms of carcinogenesis will be critically
evaluated for evidence of exposure to agent and breast cancer risk based on Òstrength of evidenceÓ approach, according to a
modification of IARC criteria as listed in the IARC Preamble.  (See below for a more detailed explanation of the BCERF
Carcinogenicity classification scheme)
The emphasis of the document will be on critical evaluation of the evidence for breast cancer carcinogenicity, classification of the
agentÕs breast cancer risk, identification of research gaps, and recommendations for future studies.  A section will also be devoted to
brief summaries of new research studies that are in progress.  A bibliography with all cited literature is included in each critical
evaluation.  Major international, federal and state agencies will be provided with copies of our report.
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General Outline of BCERF Critical Evaluations
I. Chemical Information
A. Common Name
B. Chemical Name(s)
C. Chemical Formula(s)
D. Trade Name(s)
E. CAS # (Chemical Abstract Subject Number)
F. Chemical Structure
II. History of Use
1. Date of first registration
2. Uses
3. Past Usage / If available, current usage levels in US and NYS
III. Current Regulatory Status
A. Current Regulatory Status, EPA
B. Other sections as applicable
IV. Summary on Evidence of Overall Carcinogenicity (Non-Breast Sites)
A. Human Studies
B. Animal Studies
C. Current Classification of Carcinogenicity by other Agencies
1. IARC (International Agency for Research on Cancer)
2. NTP (National Toxicology Program)
3. EPA (Environmental Protection Agency)
V.  Critical Evaluation of the Scientific Evidence for Breast Carcinogenicity
A. Humans Studies will include:
1. Case-Studies
2. Human Epidemiological Cohort Studies
3. Human Epidemiological Case-Control Studies
B. Experimental Animal Studies
C. Other Relevant Information, including mechanisms by which exposure may affect breast cancer risk (examples: co-
carcinogenicity, estrogenicity, endocrine disruptor, mutagenicity, tumor promotion, cell proliferation, oncogene/tumor
suppressor gene expression, immune function, etc.)
VI.  Other Relevant Information
A. Specific for the pesticide; (i.e. may include information on environmental fate)
B. When available will summarize information on detection /accumulation in human tissues / and validation of biomarkers
VII.  Summary, Conclusions, Recommendation for Classification
VIII. Identification of Research Gaps, and Other Recommendations
IX.   Brief Summaries of New Human Studies Currently Being Conducted
X.    Bibliography
XI.   Appendix A. Common Abbreviations, Acronyms and Symbols
XII.  Appendix B. Critical Evaluations of Breast Carcinogenicity
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BCERF Breast Carcinogenicity Classification Scheme
(adapted from the IARC Preamble by S.M.Snedeker)
Group 1:  Human breast carcinogen; sufficient evidence of
carcinogenicity to humans is necessary.  Sufficient evidence is
considered to be evidence that a causal relationship has been
established between exposure to the agent and human breast
cancer.
Group 2A:  Probable breast carcinogen; this category
generally includes agents for which there is 1) limited evidence
of breast carcinogenicity in humans   and   sufficient evidence  of
mammary carcinogenicity in experimental animals.  The
classification may also be used when there is 2) limited evidence
of breast carcinogenicity in humans and strong supporting
evidence from other relevant data, or when there is 3) sufficient
evidence  of mammary carcinogenicity in experimental animals
and strong supporting evidence from other relevant data.
Group 2B:  Possible breast carcinogen; this category generally
includes agents for which there is 1) limited evidence  in humans
in the absence of sufficient evidence  in experimental animals; 2)
inadequate evidence  of carcinogenicity in humans or when
human data is nonexistent but there is sufficient evidence  of
carcinogenicity in experimental animals, 3) inadequate evidence
or no data in humans but with limited evidence  of
carcinogenicity in experimental animals together with
supporting evidence from other relevant data.
Group 2C:  Potential to affect breast cancer risk; this
category includes agents for which there is inadequate or
nonexistent human and animal data, but there is
supporting evidence from other relevant data that identifies a
mechanism by which the agent may affect breast cancer risk.
Examples are, but are not limited to:  evidence of agentÕs
estrogenicity, disruption of estrogen metabolism resulting in
potential to affect exposure to estrogen; evidence of breast  tumor
promotion, progression or co-carcinogenicity; increased
expression of proto-oncogenes or oncogenes; evidence of
inactivation of tumor suppressor gene associated with breast
cancer; evidence of adverse effect on immune function; or
evidence of a structural similarity to a known breast carcinogen
(structure-activity relationship).
Group 3: Not classifiable as to its breast carcinogenicity to
humans.  Agents are placed in this category when they do not
fall into any other group.
Group 4: Probably not a breast carcinogen in humans:
This category is used for agents for which there is evidence
suggesting a lack of breast carcinogenicity in human studies and
in animal studies, together with a lack of related evidence which
may predict breast cancer risk. The absence of studies does not
constitute evidence for a lack of breast carcinogenicity.
Brief Definitions of Sufficient, Limited, and Inadequate
Evidence:
(adapted for breast carcinogenicity from the IARC Preamble by
S.M. Snedeker)
Human Studies
Sufficient evidence of carcinogenicity in humans:  Must
have established evidence   between    exposure   to   the    agent    and
human   breast   cancer .  Case-reports are given the least weight in
considering carcinogenicity data in humans--they are suggestive
of a relationship, but by themselves cannot demonstrate
causality. Consistent, case-control studies which have controlled
for confounding factors and have found high relative risks of
developing breast cancer in relation to an identified exposure are
given the most weight in determining a causal relationship.
Limited evidence of breast carcinogenicity in humans:  A
positive association has been observed between exposure to the
agent and breast cancer, but chance, bias or confounding factors
could not be ruled out.
Inadequate evidence of breast carcinogenicity in humans:
The available studies are of insufficient quality, consistency or
statistical power to permit a conclusion regarding the presence
or absence of a causal association.
Experimental Animal Studies
Sufficient evidence of breast carcinogenicity in animals:
Evidence of malignant tumors or combination of benign and
malignant tumors in (a) two or more species of animals, (b) or
two or more independent studies in one species carried out at
different times or in different laboratories or under different
protocols.
Limited evidence of breast carcinogenicity in animals: The
studies suggest a carcinogenic effect, but are limited for making
a definitive evaluation because: (a) the evidence of
carcinogenicity is restricted to a single experiment; (b) there are
unresolved questions regarding the adequacy of the design,
conduct or interpretation of the study; or (c) the agent increases
the incidence of only benign neoplasms of lesions of uncertain
neoplastic potential, or of certain neoplasms which may occur
spontaneously in high incidences in certain strains of animals.
Inadequate evidence of breast carcinogenicity in animals:
The studies cannot be interpreted as showing either the presence
or absence of a carcinogenic effect because of major qualitative or
quantitative limitations.
